Clinical trials referenced in this document:
Documents that mention this clinical trial
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
https://doi.org/10.1136/ijgc-2020-001277
Documents that mention this clinical trial
Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin
https://doi.org/10.1136/ijgc-2020-001227
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
https://doi.org/10.1136/ijgc-2020-001277
Documents that mention this clinical trial
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
https://doi.org/10.1136/ijgc-2020-001277
Documents that mention this clinical trial
ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models
https://doi.org/10.1136/jitc-2023-007474
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
https://doi.org/10.1136/ijgc-2020-001277
Documents that mention this clinical trial
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
https://doi.org/10.1136/ijgc-2020-001277
Documents that mention this clinical trial
Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer types
https://doi.org/10.1007/s00280-020-04184-z
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
https://doi.org/10.1136/ijgc-2020-001277
Funding for this research was provided by:
National Medical Research Council (CSAINV16may008, MOH-FLWSHP19may-0006)